​

Funding Round

Series C - Healx

Series C - Healx

Investment Firm

Overview

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Announced Date

Aug 01, 2024

Funding Type

Series C

Highlights

Location

Europe

Social

Investor Lead

Atomico

Atomico

Atomico is a debt and early_stage_venture and late_stage_venture and seed and venture firm.

R42 Group

R42 Group

R42 Group is a convertible_note and early_stage_venture and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorGlobal Brain Corporation
Participant InvestorJonathan Milner
Participant Investorb2venture
Participant InvestorAtomico
Participant InvestorBalderton Capital

Round Details and Background

Healx raised $47000000 on 2024-08-01 in Series C

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 11, 2024
Grant - Healx
1-undefined
Aug 01, 2024
Series C - Healx
9-47.0M
Mar 07, 2016
Non Equity Assistance - Healx
1-undefined
Oct 04, 2016
Seed Round - Healx
4-1.9M

Recent Activity

There is no recent news or activity for this profile.